MAMU
NVO

Myriad Asset Management US’s Novo Nordisk NVO Stock Holding History

Myriad Asset Management US’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Buy
+6,433
New +$276K 0.43% 49

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.12B AUM 44.65% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Myriad Asset Management US's NVO Position: Q2 2026 in Review

Myriad Asset Management US opened a new position in Novo Nordisk (NVO) in Q2 2026: 6,433 shares worth $308K. The stake represents 0.43% of the portfolio and ranks #49 among its holdings.

240 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Myriad Asset Management US held 6,433 shares of Novo Nordisk worth $308K as of Q2 2026.
  • Novo Nordisk was a new Myriad Asset Management US position in Q2 2026.
  • Novo Nordisk made up 0.43% of Myriad Asset Management US's portfolio in Q2 2026, its #49 holding.
  • 240 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Myriad Asset Management US's 13F filing for Q2 2026, filed 20 Jul 2026.